Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Lymphocyte Function-Associated Antigen-1 MeSH Descriptor Data 2025


MeSH Heading
Lymphocyte Function-Associated Antigen-1
Tree Number(s)
D09.400.430.890.200.074.937
D09.400.430.890.200.625.550
D12.776.395.550.200.074.937
D12.776.395.550.200.625.550
D12.776.543.550.200.093.937
D12.776.543.550.200.625.550
D12.776.543.750.705.408.600.400
D12.776.543.750.705.877.550
D23.050.301.350.074.400
D23.050.301.350.625.550
Unique ID
D016169
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D016169
Scope Note
An integrin heterodimer widely expressed on cells of hematopoietic origin. CD11A ANTIGEN comprises the alpha chain and the CD18 antigen (CD18 ANTIGENS) the beta chain. Lymphocyte function-associated antigen-1 is a major receptor of T-CELLS; B-CELLS; and GRANULOCYTES. It mediates the leukocyte adhesion reactions underlying cytolytic conjugate formation, helper T-cell interactions, and antibody-dependent killing by NATURAL KILLER CELLS and granulocytes. Intracellular adhesion molecule-1 has been defined as a ligand for lymphocyte function-associated antigen-1.
Entry Version
LFA1
Entry Term(s)
Integrin alphaLbeta2
LFA-1
Leukocyte Function Associated Antigen-1
Registry Numbers
0
Previous Indexing
Antigens, Differentiation (1988-1990)
Receptors, Leukocyte-Adhesion (1989-1990)
Public MeSH Note
1991
History Note
1991
Date Established
1991/01/01
Date of Entry
1990/04/24
Revision Date
2023/03/16
Lymphocyte Function-Associated Antigen-1 Preferred
page delivered in 0.163s